Oncosil Medical (ASX:OSL)
ASX announcement history & article coverage
Transparent by design.
Announcments by Oncosil Medical (ASX:OSL) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notice of Annual General Meeting/Proxy Form
Application for quotation of securities - OSL
PALACROS Officially Launched in Amsterdam
OncoSil Clinical Data to be Presented at EANM 2026
Notice of AGM date
Notice under ASX Listing Rule 3.10A
Change in substantial holding
Change in substantial shareholding from AEF
Notice Under Section 708A
Application for quotation of securities - OSL
Application for quotation of securities - OSL
Australian Manufacturing Facility Achieves ISO 13485
Cyclotek ISO 13485 certification advances OncoSil Medical's Sydney manufacturing plans
100th Patient Treated with OncoSil device in Spain
Proposed issue of securities - OSL
OSL Secures $5.6 million from Major Institutional Investors
OncoSil Medical raises $5.6 million to fund US and Australian commercial launch
OncoSil submits US Reimbursement Application (Updated)
OncoSil submits US Reimbursement Application
Appendix 4G and Corporate Governance Statement
Appendix 4E and Annual Report
OncoSil Medical reports FY26 revenue growth, reduced loss, key regulatory approvals, and commercial expansion
Change in substantial holding
Change in substantial shareholding from AEF
Application for quotation of securities - OSL
Investor Webinar Presentation
OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
OncoSil Medical secures FDA approval for OncoSil™ device to treat rare bile duct cancer in U.S.
Quarterly Activities/Appendix 4C Cash Flow Report
OncoSil Medical reports strong sales growth, key clinical and regulatory milestones, and $6.5M cash at Q4 FY26
New Independent Study Confirms OncoSil Dose Flexibility
Application for quotation of securities - OSL